News + Press

Explore by Category
Select
Abstracts & Publications
Targeted in vivo Generation of CAR T and NK Cells Utilizing an Engineered Lentiviral Vector Platform
June 22, 2023

  Download the poster here.

read more
Press Release
Pennovation Lab Welcomes New Tenant Interius BioTherapeutics to Its Innovation Ecosystem
October 05, 2021
read more
Media Coverage
Interius Design: Penn Spinout Gets Specific with In Vivo CAR Ts
June 03, 2021
read more
Media Coverage
Interius Biotherapeutics Nabs $76M Series A
May 18, 2021
read more
Media Coverage
Penn Cell and Gene Therapy Spinout Interius Biotherapeutics Raises $76 Million
May 18, 2021
read more
Press Release
Interius BioTherapeutics Raises $76M Series A Financing to Advance Breakthrough Cell and Gene Therapy Platform
May 18, 2021

Interius BioTherapeutics, a preclinical stage gene therapy company developing a paradigm-shifting platform for in vivo cell-specific gene delivery, today announced that it has raised $76 million in an oversubscribed Series A financing.

read more